Accenture Completes Acquisition of Octagon Research Solutions
News Oct 14, 2012
Accenture has completed its acquisition of Octagon Research Solutions, Inc., a provider of clinical and regulatory information management solutions and software for the pharmaceutical industry based in Wayne, Pa. The acquisition was announced on Aug. 2.
The acquisition enhances Accenture's existing clinical services capabilities – including clinical data management, clinical programming and safety case processing, among others – and adds regulatory submission services, thereby extending Accenture’s business process outsourcing capabilities for the pharmaceutical industry. As a result, Accenture can now provide the first comprehensive clinical and regulatory services to pharmaceutical companies globally, helping them get medicines to market more quickly and cost effectively.
“Our pharmaceutical clients around the world are looking for proven clinical and regulatory services that can improve the efficiency and effectiveness of their drug development business,” said David Boath, North American managing director for Accenture’s Life Sciences industry group. “With Octagon’s deep regulatory expertise and proprietary software – coupled with Accenture’s global delivery network and R&D experience across the in the pharmaceutical industry – we can now offer software-enabled clinical and regulatory services solution from the initial clinical protocol design through to regulatory submission.”
Bioinformatics to Help Understand Intrinsically Disordered ProteinsNews
Over the last several decades, scientists have sequenced 85 million unique proteins, structured and unstructured alike, but still don’t know what the vast majority of these proteins do.READ MORE
Understanding the Cellular Systems that Hold Back the Spread of CancerNews
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.READ MORE